Latest News
A new Yale-led study found that administration of cognitive behavioral therapy after a course of esketamine treatment can be effective in preventing relapse in patients with major depression and suicidal ideation. Samuel Wilkinson, MD, is lead author of the study, published in The Journal of Clinical Psychiatry.
- May 06, 2026Source: JAMA Psychiatry
A systematic review and meta-analysis of 26 randomized clinical trials with 1,166 patients with a major depressive episode found that ketamine was efficacious in reducing suicidal and depressive symptoms rapidly, within hours. Greg Rhee, PhD, associate professor adjunct in psychiatry, is senior author of the paper, published in JAMA Psychiatry.
- May 06, 2026Source: JAMA Psychiatry
Greg Rhee, PhD, associate professor adjunct in psychiatry, is senior author of a paper in JAMA Psychiatry that evaluates how FDA–approved atypical antipsychotics in major depressive disorder compare with respect to overall efficacy and acceptability.
- April 21, 2026Source: Neuropsychopharmacology
Sophie Holmes, PhD, assistant professor of psychiatry, is first author of a paper in Neuropsychopharmacology that explores the use of molecular imaging to guide the development of treatments that could reduce the burden of late-life depression.
- April 07, 2026
Ben Coleman, MD, PhD, and Ann Johnson, PhD, will join the Albert J. Solnit Integrated Child, Adolescent, and Adult Psychiatry Program at Yale Child Study Center as new residents this summer. Coleman and Johnson were announced as part of the Department of Psychiatry’s 2026 Match Class, after the annual match process concluded in March.
- March 09, 2026Source: NBC Connecticut (with Dr. Robert Ostroff)
“During the winter months, we’re robbed of exposure to sunlight. In order to have vitamin D metabolized, you need sunlight. So people have low vitamin D levels, which is linked to depression,” said Robert Ostroff, MD, co-medical director of Interventional Psychiatry Service at Yale New Haven Psychiatric Hospital and clinical professor of Psychiatry at Yale School of Medicine.
- March 04, 2026Source: JAMA
Greg Rhee, PhD, associate professor adjunct in psychiatry, is senior author of a paper in JAMA that found adolescents are suffering from insufficient sleep and that the problem is particularly pronounced among those with depressive symptoms or suicidal thoughts.
- January 08, 2026Source: WFSB-TV Channel 3
One week into the new year, thousands of people across the country are participating in “Dry January,” a challenge to cut out alcohol for the entire month. “It’s a way of resetting after holiday spirits get a little bit out of hand and people tend to overdrink and overeat,” said Robert Ostroff, MD, co-medical director of interventional psychiatry at Yale New Haven Psychiatric Hospital.
- December 18, 2025Source: BMJ Mental Health
Greg Rhee, PhD, associate professor adjunct in psychiatry, is first author of a paper in BMJ Mental Health that reviews the effects of electroconvulsive therapy on all-cause mortality and suicide deaths in severe unipolar or bipolar depression using longitudinal studies.
- October 30, 2025Source: eClinical Medicine
Greg Rhee, PhD, associate professor adjunct in psychiatry, is senior author of a paper in eClinical Medicine that compares the effectiveness of repetitive transcranial magnetic stimulation, intranasal esketamine, and pharmacotherapy for treatment-resistant depression using data from two clinical trials.